Lukasz Gondek, MD, Oncology, Baltimore, MD, Johns Hopkins Hospital

LukaszPawelGondekMDPhD

Oncology Baltimore, MD

Hematologic Oncology

Assistant Professor of Oncology, Johns Hopkins University School of Medicine

Dr. Gondek is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gondek's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology/Oncology, 2011 - 2014
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2008 - 2011
  • Medical University of Silesia
    Medical University of SilesiaClass of 2003

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2011 - 2022
  • OH State Medical License
    OH State Medical License 2008 - 2013
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Abstracts/Posters

  • Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis
    Lukasz P. Gondek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant Abstract
    Lukasz P. Gondek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Clinical Management of Myeloid Malignancies: The Coming of Age of Targeted Therapies 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Genomic Features of AML in Patients over Age 60 Can Predict Success of Bone Marrow Stem Cell Transplant, Research Shows
    Genomic Features of AML in Patients over Age 60 Can Predict Success of Bone Marrow Stem Cell Transplant, Research ShowsDecember 10, 2019 21:39

Other Languages

  • Polish

Hospital Affiliations